Sign In
to Vote &
Create Storyboards.
 
Investigators report the first successful use of a targeted therapy to treat a patient with BRAF-mutant craniopharyngioma, a debilitating, recurrent brain tumor.
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard